S. Madhavan’s appointment will be effective on April 1, 2025.
Mumbai, India – February 6, 2025 – P&G Health has announced the appointment of S. Madhavan, an Independent Director of the company, as the new Chairperson. As per the company, the appointment will be effective on April 1, 2025.
Madhavan’s appointment marks a new phase in the company’s leadership and governance as he takes on this crucial role. This leadership transition reflects the company’s commitment to maintaining strong governance while preparing for the future.
Further to the changes, the Board of Directors, in a meeting held today, has announced the retirement of Suresh Talwar, Independent Director and Chairperson, and Rani Ajit Jadhav, Independent Director, upon the completion of their second tenure. As per the company, the retirement will be effective from March 31, 2025.
The company expressed its deep appreciation for the valuable leadership, guidance, and counsel provided by both directors throughout their tenure. In a statement, the management thanked Talwar and Jadhav for their contributions and the direction they have provided during their time on the Board.
“The management expresses its deepest gratitude for the years of valuable guidance, leadership, counsel, and direction provided by the Directors during their tenure as Independent Directors on the Board,” the company stated.
About P&G Health
Procter & Gamble Health Limited was set up in India as one of Merck’s Asian subsidiaries in 1967. It was also the first Merck Group Company to go public in the year 1981. Until 2018, the company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country.
On December 1, 2018, P&G successfully completed the acquisition of Merck’s Consumer Health business, following approval from all relevant regulatory authorities and the fulfillment of other customary closing conditions. Procter & Gamble Overseas India B.V. now holds 51.81% of the share capital in Merck Limited, while the remaining 48.19% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.
Today, Procter & Gamble Health Limited is one of India’s largest VMS Companies, manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements to support a healthy lifestyle and improved quality of life.
With a strong portfolio of brands backed by science and trusted by doctors, pharmacists, and consumers, Procter & Gamble Health Limited combines the best of P&G and Legacy Merck’s Consumer Health capabilities and cultures. Together, the company is working towards leveraging combined expertise to develop categories and brands that meet today’s needs and tomorrow’s opportunities.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
